Form 8-K ENANTA PHARMACEUTICALS For: Jun 23
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/27/2026
- S&P 500 ends lower; chips tumble and Moderna rallies
- SpaceX weighs Starlink mobile service to US consumers, FT reports
- U.S. chip stocks retreat after Apple price hikes stoke fears over AI trade
- Morgan Stanley flags Fed hike risk if unemployment drops below 4%
- UBS trims AI portfolio exposure to semis and hardware after recent rally
Enanta Pharma loses appeal in Pfizer Paxlovid patent case
June 23, 2026 5:30 PM EDTEnanta Pharmaceuticals (NASDAQ: ENTA) lost its patent infringement appeal against Pfizer Inc. after the United States Court of Appeals for the Federal Circuit ruled on June 23, 2026, that the claims of U.S. Patent No. 11,358,953 were invalid.
The Federal Circuit's decision affirmed a December... More
